Drug Research
FDA approves Aleors Diclofenac sodium topical solution
The US Food and Drug Administration (FDA) has granted tentative approval for Aleor Dermaceuticals’ Diclofenac sodium topical solution USP, 2% w / w to treat...
IT & Data Management
High Purity New England Launches Single Use Mixing System
High Purity New England, a leading supplier of biotech equipment and process systems for the Biotech industry, has launched ClearMixx, an innovative single use mixing...
Clinical Trials
ImmuPharma signs agreement with Avion for Lupuzor
UK-based pharmaceutical company ImmuPharma has signed a licensing and development agreement with US-based Avion Pharmaceuticals for Lupuzor, a peptide therapeutic and a first-in-class autophagy immunomodulator...
Clinical Trials
Inceptua and Bendalis enter into an exclusive oncology medicine...
The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs and special therapeutic...
Clinical Trials
ERYTECH Announces Publication of its Phase 2b Trial of...
ERYTECH Pharma a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that the full results from its...
Drug Research
Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for...
Hutchison China MediTech Limited announces that the U.S. FDA has granted Orphan Drug designation to surufatinib for the treatment of pancreatic neuroendocrine tumors.
“NET is an...
Drug Research
Bayer and Dewpoint Therapeutics partner to research new treatments...
Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, announced an option, research and license agreement worth up to USD...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.